233 related articles for article (PubMed ID: 36118173)
1. Consensus docking and MM-PBSA computations identify putative furin protease inhibitors for developing potential therapeutics against COVID-19.
Dankwa B; Broni E; Enninful KS; Kwofie SK; Wilson MD
Struct Chem; 2022; 33(6):2221-2241. PubMed ID: 36118173
[TBL] [Abstract][Full Text] [Related]
2. Cheminformatics-Based Identification of Potential Novel Anti-SARS-CoV-2 Natural Compounds of African Origin.
Kwofie SK; Broni E; Asiedu SO; Kwarko GB; Dankwa B; Enninful KS; Tiburu EK; Wilson MD
Molecules; 2021 Jan; 26(2):. PubMed ID: 33466743
[TBL] [Abstract][Full Text] [Related]
3. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
[TBL] [Abstract][Full Text] [Related]
4. Computational Identification of Potential Anti-Inflammatory Natural Compounds Targeting the p38 Mitogen-Activated Protein Kinase (MAPK): Implications for COVID-19-Induced Cytokine Storm.
Asiedu SO; Kwofie SK; Broni E; Wilson MD
Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33946644
[TBL] [Abstract][Full Text] [Related]
5. Dietary polyphenols mitigate SARS-CoV-2 main protease (Mpro)-Molecular dynamics, molecular mechanics, and density functional theory investigations.
Adelusi TI; Oyedele AK; Monday OE; Boyenle ID; Idris MO; Ogunlana AT; Ayoola AM; Fatoki JO; Kolawole OE; David KB; Olayemi AA
J Mol Struct; 2022 Feb; 1250():131879. PubMed ID: 34785822
[TBL] [Abstract][Full Text] [Related]
6. Benchmarked molecular docking integrated molecular dynamics stability analysis for prediction of SARS-CoV-2 papain-like protease inhibition by olive secoiridoids.
Thangavel N; Albratty M
J King Saud Univ Sci; 2023 Jan; 35(1):102402. PubMed ID: 36338939
[TBL] [Abstract][Full Text] [Related]
7. Computational Study on Potential Novel Anti-Ebola Virus Protein VP35 Natural Compounds.
Darko LKS; Broni E; Amuzu DSY; Wilson MD; Parry CS; Kwofie SK
Biomedicines; 2021 Nov; 9(12):. PubMed ID: 34944612
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 liver and gastroenterology findings: An
Peiter GC; de Souza CBT; de Oliveira LM; Pagliarin LG; Dos Anjos VNF; da Silva FAF; de Melo FF; Teixeira KN
World J Hepatol; 2022 Jun; 14(6):1131-1141. PubMed ID: 35978663
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner.
Lavie M; Dubuisson J; Belouzard S
J Virol; 2022 Jul; 96(13):e0047422. PubMed ID: 35678602
[TBL] [Abstract][Full Text] [Related]
10. Identification, virtual screening and molecular dynamic analysis of novel TMPRSS2 inhibitors from natural compound database as potential entry-blocking agents in SARS-CoV-2 therapy.
Manandhar S; Pai KSR; Krishnamurthy PT; Kiran AVVVR; Kumari GK
Struct Chem; 2022; 33(5):1609-1617. PubMed ID: 35754942
[TBL] [Abstract][Full Text] [Related]
11. Identification of some dietary flavonoids as potential inhibitors of TMPRSS2 through protein-ligand interaction studies and binding free energy calculations.
Varughese JK; J K; S SK; Francis D; L JLK; G AT
Struct Chem; 2022; 33(5):1489-1502. PubMed ID: 35645548
[TBL] [Abstract][Full Text] [Related]
12. Virtual screening by targeting proteolytic sites of furin and TMPRSS2 to propose potential compounds obstructing the entry of SARS-CoV-2 virus into human host cells.
Vardhan S; Sahoo SK
J Tradit Complement Med; 2022 Jan; 12(1):6-15. PubMed ID: 33868970
[TBL] [Abstract][Full Text] [Related]
13. Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling.
Frolova EI; Palchevska O; Lukash T; Dominguez F; Britt W; Frolov I
J Virol; 2022 Aug; 96(15):e0075322. PubMed ID: 35876526
[TBL] [Abstract][Full Text] [Related]
14. Computational assessment of select antiviral phytochemicals as potential SARS-Cov-2 main protease inhibitors: molecular dynamics guided ensemble docking and extended molecular dynamics.
Sawant S; Patil R; Khawate M; Zambre V; Shilimkar V; Jagtap S
In Silico Pharmacol; 2021; 9(1):44. PubMed ID: 34306960
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of honokiol on furin-like activity and SARS-CoV-2 infection.
Tanikawa T; Hayashi T; Suzuki R; Kitamura M; Inoue Y
J Tradit Complement Med; 2022 Jan; 12(1):69-72. PubMed ID: 34545325
[TBL] [Abstract][Full Text] [Related]
16. Pharmacoinformatics-based identification of potential bioactive compounds against Ebola virus protein VP24.
Kwofie SK; Broni E; Teye J; Quansah E; Issah I; Wilson MD; Miller WA; Tiburu EK; Bonney JHK
Comput Biol Med; 2019 Oct; 113():103414. PubMed ID: 31536833
[TBL] [Abstract][Full Text] [Related]
17. Computational screening of dual inhibitors from FDA approved antiviral drugs on SARS-CoV-2 spike protein and the main protease using molecular docking approach.
Sabarimurugan S; Purushothaman I; Swaminathan R; Dharmarajan A; Warrier S; Kothandan S
Acta Virol; 2021; 65(2):160-172. PubMed ID: 34130467
[TBL] [Abstract][Full Text] [Related]
18. Targeting COVID-19 pandemic: in silico evaluation of 2-hydroxy-1, 2-diphenylethanone N(4)-methyl-N(4)-phenylthiosemicarbazone as a potential inhibitor of SARS-CoV-2.
Jeevana R; Kavitha AP; Abi TG; Sajith PK; Varughese JK; Aravindakshan KK
Struct Chem; 2022 Oct; ():1-17. PubMed ID: 36274924
[TBL] [Abstract][Full Text] [Related]
19. Metalloproteinase-Dependent and TMPRSS2-Independent Cell Surface Entry Pathway of SARS-CoV-2 Requires the Furin Cleavage Site and the S2 Domain of Spike Protein.
Yamamoto M; Gohda J; Kobayashi A; Tomita K; Hirayama Y; Koshikawa N; Seiki M; Semba K; Akiyama T; Kawaguchi Y; Inoue JI
mBio; 2022 Aug; 13(4):e0051922. PubMed ID: 35708281
[TBL] [Abstract][Full Text] [Related]
20. Term Human Placental Trophoblasts Express SARS-CoV-2 Entry Factors ACE2, TMPRSS2, and Furin.
Ouyang Y; Bagalkot T; Fitzgerald W; Sadovsky E; Chu T; Martínez-Marchal A; Brieño-Enríquez M; Su EJ; Margolis L; Sorkin A; Sadovsky Y
mSphere; 2021 Apr; 6(2):. PubMed ID: 33853873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
